Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Anne Layne-Farrar has joined the firm as a vice president in the Antitrust & Competition Economics Practice based in Chicago. Dr. Layne-Farrar specializes in antitrust and intellectual property matters, especially where the two issues intersect.
“Anne Layne-Farrar is a leading expert in the antitrust implications of intellectual property,” said CRA's President and Chief Executive Officer Paul Maleh. “She is a seasoned economist and expert testifier, and is highly experienced in working with multinational corporations and antitrust challenges in multiple jurisdictions. She is a great addition to CRA’s global Antitrust & Competition Economics team and it is a pleasure to welcome her to CRA.”
Dr. Layne-Farrar advises clients on competition, intellectual property, regulation, and policy issues as well as private litigation and competition agency investigations across a broad range of industries with a particular focus on high-tech. She has worked with some of the largest information technology, communications, and pharmaceutical companies in the world. Her advisory work for industry leading clients has included: analyzing reasonable licensing, including RAND and FRAND; analyzing patent filings for market definition; assessing economic incentives and firm behavior within standard setting organizations; reviewing the competitive implications of licensing pharmaceuticals; calculating damages; conducting empirical research on the costs and benefits of payment instruments within the United States; and determining costs and benefits for legislative proposals covering credit and debit cards, labor unions, television ratings, software security, and e-commerce.
Dr. Layne-Farrar has offered economic analysis in a variety of national and international courts and she regularly presents about the economics of competition and intellectual property issues to governmental agencies, such as the Federal Trade Commission, and industry leading conferences. In addition, she has published extensively, including 30 journal articles, this year’s recently published book EU Competition Law & Economics (co-authored with Damien Geradin and Nicolas Petit), and more than 20 magazine articles and working papers. Dr. Layne-Farrar joins CRA from Compass Lexecon and she held prior roles with LECG, NERA Economic Consulting, and Lexecon, Inc. Dr. Layne-Farrar holds PhD and MA degrees in Economics from the University of Chicago, and a BA degree in Economics from Indiana University.About Charles River Associates (CRA) Charles River Associates® is a global consulting firm specializing in litigation, regulatory, and financial consulting, and management consulting. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout North America, Europe, the Middle East, and Asia. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at http://www.crai.com. Statements in this press release concerning Anne Layne-Farrar, any future business Dr. Layne-Farrar may generate for the Company or the Antitrust & Competition Economics Practice, the future business, operating results, estimated cost savings, and financial condition of the Company and statements using the terms "anticipates," "believes," "expects," "should," "prospects," "target," or similar expressions are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based upon management's current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual performance or results to differ materially from any forward-looking statements made by the Company include, among others, the Company's restructuring costs and attributable annual cost savings, changes in the Company's effective tax rate, share dilution from the Company's stock-based compensation, dependence on key personnel, attracting, recruiting and retaining qualified consultants, dependence on outside experts, utilization rates, completing acquisitions and factors related to its completed acquisitions, including integration of personnel, clients and offices, and unanticipated expenses and liabilities, the risk of impairment write downs to the Company's intangible assets, including goodwill, if the Company's enterprise value declines below certain levels, risks associated with acquisitions it may make in the future, risks inherent in international operations, the performance of NeuCo, changes in accounting standards, rules and regulations, changes in the law that affect the Company's practice areas, management of new offices, the potential loss of clients, the ability of customers to terminate the Company's engagements on short notice, dependence on the growth of the Company's management consulting practice, the unpredictable nature of litigation-related projects, the ability of the Company to integrate successfully new consultants into its practice, general economic conditions, intense competition, risks inherent in litigation, and professional liability. Further information on these and other potential factors that could affect the Company's financial results is included in the Company's periodic filings with the Securities and Exchange Commission. The Company cannot guarantee any future results, levels of activity, performance or achievement. The Company undertakes no obligation to update any of its forward-looking statements after the date of this press release.